AbCellera Biologics Inc vs Allbirds Inc — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while Allbirds Inc trades at $2.59 (market cap $30.00M). The key difference: AbCellera Biologics Inc is far larger — about 99.7× Allbirds Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | BIRD | |
|---|---|---|
Market Cap | $2.99B | $30.00M |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $16.99 |
52-Week Low | $2.78 | $2.21 |
Enterprise Value | $2.58B | $48.86M |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →